Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy

Anthracycline-induced cardiomyopathy is a leading cause of late morbidity in childhood cancer survivors. Aberrant DNA methylation plays a role in de novo cardiovascular disease. Epigenetic processes could play a role in anthracycline-induced cardiomyopathy but remain unstudied. We sought to examine...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Purnima, Zhou, Liting, Shah, Disheet A., Cejas, Romina B., Crossman, David K., Jouni, Mariam, Magdy, Tarek, Wang, Xuexia, Sharafeldin, Noha, Hageman, Lindsey, McKenna, Donald E., Horvath, Steve, Armenian, Saro H., Balis, Frank M., Hawkins, Douglas S., Keller, Frank G., Hudson, Melissa M., Neglia, Joseph P., Ritchey, A. Kim, Ginsberg, Jill P., Landier, Wendy, Burridge, Paul W., Bhatia, Smita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403495/
https://www.ncbi.nlm.nih.gov/pubmed/37542143
http://dx.doi.org/10.1038/s41598-023-39357-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403495/
https://www.ncbi.nlm.nih.gov/pubmed/37542143
http://dx.doi.org/10.1038/s41598-023-39357-2

Ejemplares similares